费尔巴酸盐的 urolithiasis 的发生
Ilana Bergelson1, Chance Walker2,3, Elizabeth L Frank3,4
1Department of Urology, The University of Iowa Hospitals and Clinics, Iowa City, lowa, USA ilana-bergelson@uiowa.edu.
BMJ case reports
|December 21, 2023
概括
药物诱导的甲是多种药物治疗患者的风险. 这一案例突出了成年人的石,强调了石头分析和神经科医生和泌尿科医生之间的沟通的必要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 药物诱导的结石是重复结石和多药物治疗的患者的一个重大问题.
- 费尔巴酸甲病已在儿科患者中记录,但很少在成年人中出现.
研究的目的:
- 报告已知最古老的费尔巴酸甲状腺瘤病例,发生在成人患者身上.
- 强调石头分析和跨学科沟通在治疗药物诱导结石方面的重要性.
主要方法:
- 一个30多岁的成年男性患有莱诺克斯-加斯托综合征的病例报告.
- 对临床表现,药物史 (felbamate) 和石头分析的审查.
主要成果:
- 尽管患者服用了适度剂量,但患者患上了felbamate石头,这表明药物血清水平可能很高.
- 石头分析对于识别与药物相关的石头至关重要,特别是当结果不确定且没有感染时.
结论:
- 费尔巴酸盐结石可以发生在成年患者身上,即使使用标准剂量.
- 泌尿科医生必须对药物诱导的结石保持高度怀疑,并与神经科医生合作,以防止其复发.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
184
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
184
Antiepileptic Drugs: Glutamate Antagonists
376
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
Drugs for Treatment of Diarrhea-Predominant IBS
179
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
179
Drugs for Treatment of Constipation-Predominant IBS
176
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
176
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators
412
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
412


